中國聖牧(01432.HK)擬向認購方B配發1.41億股認股權證股份
格隆匯 8 月 3日丨中國聖牧(01432.HK)發佈公告,2020年7月31日,公司接獲認購方B的行使通知,認購方B將以每股認股權證股份0.33港元的行使價行使全部140,862,105份認股權證B以認購140,862,105股認股權證股份。公司確認已於2020年8月3日收到合共約4648.45萬港元,即應付140,862,105股認股權證股份的總認購價。
根據認股權證B的條款,公司須於2020年8月6日向認購方B配發及發行合共140,862,105股認股權證股。該等認股權證股份彼此之間及與於配發及發行該等認股權證股份當日所有已發行股份在所有方面均享有同等地位,並將佔經配發及發行140,862,105股認股權證股份擴大後的公司已發行股本的約1.68%。於行使上述認股權證B的認購權後,認購方B將無尚未行使的認股權證B的認購權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.